| Aurobindo Pharma Ltd.
has posted good results for the year ended 31st March, 2002. Total Income for the year
registered a growth of 4.43% and amounted to
Rs.1052.40 crores (Rs. 1007.75 crore), while Profit before depreciation, interest and tax for
the year stood at Rs. 137.04 crores (Rs. 139.89
crore).
After
taking into account extra-ordinary income (from sale of brands) of Rs. 10.00 crores and
providing interest of Rs.42.39 crores (Rs.41.68 crore), depreciation of
Rs.15.81 crores (Rs.14.78 crore) and provision for taxation (including deferred tax and
adjustment of previous years) of Rs.20.33 crore (Rs.15.12 crore), the Net Profit for the year
stood at Rs.68.51 crores ( Rs.68.31 crore).
The Company has strong
fundamentals and as at 31st March, 2002, Reserves and Surplus stood at Rs.340.69
crore on an equity base of Rs.20.67 crore. |